Melanie Brooke Bernhardt

Chief Pharmaceutical Officer, Associate Member, and Vice-Chair

St. Jude Children's Research Hospital

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Nader K. El‐Mallawany

UNITED STATES

View details

Zachary T. Ball

Rice University

UNITED STATES

View details

Karen Rabin

Professor

Baylor College of Medicine

UNITED STATES

View details

Michele S. Redell

Baylor College of Medicine

UNITED STATES

View details

Austin Brown

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Michael Scheurer

Professor

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Melanie Brooke Bernhardt

Research Interests

Explore related searches

Contact this professor

Articles (10)

Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated

Safety analysis of high‐dose methotrexate in pediatric non‐Hodgkin lymphomas

Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group

Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene

Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges

Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia

The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority—An oncology perspective

Association of Rituximab Use with Adverse Events in Children, Adolescents, and Young Adults

Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia

Collaborators (6)

Nader K. El‐Mallawany

Zachary T. Ball

Karen Rabin

Michele S. Redell

Austin Brown

Michael Scheurer

Make your next move.